LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 40

Search options

  1. Article ; Online: The complete mitochondrial genome of the Baishanzu horned toad

    Wu, Jian-Ping / Wu, Jia-Lian / Chen, Yun-Bo / Xu, Wei-Hua / Xie, Wen-Qi / Tang, Zi-Qiang / Ding, Guo-Hua / Ma, Li

    Mitochondrial DNA. Part B, Resources

    2024  Volume 9, Issue 1, Page(s) 209–213

    Abstract: The mitochondrial genome (mitogenome) ... ...

    Abstract The mitochondrial genome (mitogenome) of
    Language English
    Publishing date 2024-01-30
    Publishing country England
    Document type Journal Article
    ISSN 2380-2359
    ISSN (online) 2380-2359
    DOI 10.1080/23802359.2024.2307995
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Berberine Ameliorates Lipopolysaccharide-Induced Cognitive Impairment Through SIRT1/NRF2/NF-κB Signaling Pathway in C57BL/6J Mice.

    Chen, Nan / Wang, Xin-Chen / Fan, Ling-Ling / Zhu, Yu-Huang / Wang, Qi / Chen, Yun-Bo

    Rejuvenation research

    2022  Volume 25, Issue 5, Page(s) 233–242

    Abstract: The inflammatory response is the stress reactions to infection or injury so as to help the body return to normal as soon as possible. In central nervous system, the overactivated immune system causes irreversible damage to neurons and synapses, which ... ...

    Abstract The inflammatory response is the stress reactions to infection or injury so as to help the body return to normal as soon as possible. In central nervous system, the overactivated immune system causes irreversible damage to neurons and synapses, which results in cognitive impairment. Berberine, an isoquinoline alkaloid extracted from
    MeSH term(s) Animals ; Mice ; Anti-Inflammatory Agents/pharmacology ; Antioxidants/pharmacology ; Berberine/pharmacology ; Berberine/therapeutic use ; Cognitive Dysfunction/drug therapy ; Drugs, Chinese Herbal/pharmacology ; Heme Oxygenase-1/metabolism ; Heme Oxygenase-1/pharmacology ; Isoquinolines/pharmacology ; Lipopolysaccharides/pharmacology ; Mice, Inbred C57BL ; NF-E2-Related Factor 2/metabolism ; NF-kappa B/metabolism ; Signal Transduction ; Sirtuin 1/metabolism
    Chemical Substances Anti-Inflammatory Agents ; Antioxidants ; Berberine (0I8Y3P32UF) ; Drugs, Chinese Herbal ; Heme Oxygenase-1 (EC 1.14.14.18) ; Isoquinolines ; Lipopolysaccharides ; NF-E2-Related Factor 2 ; NF-kappa B ; Sirt1 protein, mouse (EC 3.5.1.-) ; Sirtuin 1 (EC 3.5.1.-) ; Nfe2l2 protein, mouse
    Language English
    Publishing date 2022-09-26
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2150779-X
    ISSN 1557-8577 ; 1549-1684
    ISSN (online) 1557-8577
    ISSN 1549-1684
    DOI 10.1089/rej.2022.0023
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Efficacy of ceftazidime-avibactam in the treatment of carbapenem-resistant Klebsiella pneumoniae infections: Focus on solid organ transplantation recipients.

    Hu, Juan / Zha, Lei / Yu, Yong-Wei / Su, Qun / Fang, Xue-Ling / Ji, Jin-Ru / Shen, Ping / Chen, Yun-Bo / Zheng, Xia / Xiao, Yong-Hong

    International journal of antimicrobial agents

    2024  Volume 63, Issue 5, Page(s) 107152

    Abstract: Introduction: Ceftazidime-avibactam (CAZ-AVI) is a new option to treat KPC- and OXA-48 carbapenem-resistant Klebsiella pneumoniae (CRKP) infections. However, clinical evidence is limited regarding its use in treating CRKP infections, especially in solid ...

    Abstract Introduction: Ceftazidime-avibactam (CAZ-AVI) is a new option to treat KPC- and OXA-48 carbapenem-resistant Klebsiella pneumoniae (CRKP) infections. However, clinical evidence is limited regarding its use in treating CRKP infections, especially in solid organ transplantation (SOT) recipients. In this study, we assessed the efficacy of CAZ-AVI in treating CRKP infections in both the general population and the SOT recipients in comparison with other antibiotic regimens.
    Methods: This is a single-centre retrospective cohort study of patients admitted between January 1, 2018 and June 30, 2021 with the diagnosis of CRKP infections receiving either CAZ-AVI or other regimens ≥ 72 hours and clinical outcomes were analysed.
    Results: Of 200 patients with CRKP infections, 67 received CAZ-AVI, 133 received other regimens, and 50 were SOT recipients. In the SOT cohort, 30 patients received CAZ-AVI, and 20 received other regimens. The overall 30-day mortality was 38% in the SOT cohort. Compared with patients receiving other regimens, CAZ-AVI therapy resulted in lower 30-day mortality (23.3% vs. 60%, P = 0.014) and 90-day mortality (35.7% vs. 86.7%, P = 0.003), higher clinical cure (93.3% vs. 40%, P < 0.001) and microbiological clearance. Similar promising results of CAZ-AVI were also shown in the whole population cohort. Moreover, clinical outcomes of SOT recipients receiving CAZ-AVI were not inferior to those without SOT.
    Conclusions: CAZ-AVI therapy was associated with better clinical outcomes in CRKP infections in both the general population and SOT recipients. Considering the limitations of the present study, well-conducted RCTs are still warranted to confirm these findings.
    Language English
    Publishing date 2024-03-19
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 1093977-5
    ISSN 1872-7913 ; 0924-8579
    ISSN (online) 1872-7913
    ISSN 0924-8579
    DOI 10.1016/j.ijantimicag.2024.107152
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Quercetin ameliorates diabetic encephalopathy through SIRT1/ER stress pathway in db/db mice.

    Hu, Tian / Shi, Jing-Jing / Fang, Jiansong / Wang, Qi / Chen, Yun-Bo / Zhang, Shi-Jie

    Aging

    2020  Volume 12, Issue 8, Page(s) 7015–7029

    Abstract: Studies have shown that diabetes is an important risk factor for cognitive dysfunction, also called diabetic encephalopathy (DE). Quercetin has been reported to be effective in improving cognitive dysfunction in DE. But its detailed mechanism is still ... ...

    Abstract Studies have shown that diabetes is an important risk factor for cognitive dysfunction, also called diabetic encephalopathy (DE). Quercetin has been reported to be effective in improving cognitive dysfunction in DE. But its detailed mechanism is still ambiguous. In this study, we used db/db mice to investigate whether quercetin could activate SIRT1 and inhibit ER pathways to improve DE. Behavioral tests (Morris water maze and new objects) showed that quercetin (70 mg/kg) can effectively improve the learning and memory ability in db/db mice. OGTT and ITT tests indicated that quercetin could alleviate impaired glucose tolerance and insulin resistance in db/db mice. Western blot analysis and Nissl staining showed that quercetin can improve the expression of nerve and synapse-associated proteins (PSD93, PSD95, NGF and BDNF) and inhibit neurodegeneration. Meanwhile, quercetin up-regulates SIRT1 protein expression and inhibits the expression of ER signaling pathway-related proteins (PERK, IRE-1α, ATF6, eIF2α, BIP and PDI). In addition, oxidative stress levels were significantly reduced after quercetin treatment. In conclusion, current experimental results indicated that SIRT1/ER stress is a promising mechanism involved in quercetin-treated diabetic encephalopathy.
    MeSH term(s) Animals ; Cognitive Dysfunction/prevention & control ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/drug therapy ; Diabetes Mellitus, Type 2/metabolism ; Endoplasmic Reticulum Stress/drug effects ; Female ; Insulin Resistance ; Learning Disabilities/prevention & control ; Memory Disorders/prevention & control ; Mice ; Neurodegenerative Diseases/prevention & control ; Oxidative Stress/drug effects ; Quercetin/pharmacology ; Quercetin/therapeutic use ; Signal Transduction/drug effects ; Sirtuin 1/physiology
    Chemical Substances Quercetin (9IKM0I5T1E) ; Sirt1 protein, mouse (EC 3.5.1.-) ; Sirtuin 1 (EC 3.5.1.-)
    Language English
    Publishing date 2020-04-20
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1945-4589
    ISSN (online) 1945-4589
    DOI 10.18632/aging.103059
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Prediction of Clostridium difficile infection based on gut microbial traits in patients with Clostridium difficile colonization.

    Yan, Dong / Huang, Yan-Di / Chen, Yun-Bo / Lv, Tao / Zhu, Chun-Xia / Huang, Jian-Rong / Li, Lan-Juan

    Hepatobiliary & pancreatic diseases international : HBPD INT

    2021  Volume 20, Issue 3, Page(s) 298–300

    MeSH term(s) Clostridioides difficile ; Clostridium Infections/diagnosis ; Feces ; Gastrointestinal Microbiome ; Humans
    Language English
    Publishing date 2021-03-21
    Publishing country Singapore
    Document type Letter
    ZDB-ID 2241386-8
    ISSN 1499-3872
    ISSN 1499-3872
    DOI 10.1016/j.hbpd.2021.03.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Danggui-Shaoyao-San improves cognitive impairment through inhibiting O-GlcNAc-modification of estrogen α receptor in female db/db mice

    Shi, Jing-Jing / Liu, Hao-Fei / Hu, Tian / Gao, Xin / Zhang, Yong-Bin / Li, Wei-Rong / Wang, Qi / Zhang, Shi-Jie / Tang, Dan / Chen, Yun-Bo

    Journal of ethnopharmacology. 2021 Dec. 05, v. 281

    2021  

    Abstract: The traditional Chinese medicine formula Danggui-Shaoyao-San (DSS) has been reported to show therapeutic effect on dementia.The present study aims to investigate whether DSS treatment could alleviate diabetes-induced cognitive dysfunction, and explores ... ...

    Abstract The traditional Chinese medicine formula Danggui-Shaoyao-San (DSS) has been reported to show therapeutic effect on dementia.The present study aims to investigate whether DSS treatment could alleviate diabetes-induced cognitive dysfunction, and explores its neuroprotective mechanism on db/db mice.The female db/db mice were randomly divided into model group, DSS low-dose group and DSS high-dose group. Homologous female db/m mice were used as the control group. DSS was intragastric administrated for 15 weeks. Glucose tolerance, insulin tolerance, blood glucose and blood lipid levels were measured. Morris water maze was used to measure spatial learning and memory ability in mice. Nissl staining and Tunel staining were used to measure the changes of brain neurons, and ELISA kits were used to measure levels of inflammatory mediators (PGE2, TXB2 and LTB4). The kits detected oxidative stress (MDA, SOD, CAT, GSH-PX), nitrosative stress (NO, iNOS, TNOS) and glucose metabolism (LDH, PK, HK) levels. Western blot and immunofluorescence detected neurotrophic factors (PSD95, BDNF, NGF and SYN), apoptosis (Bcl-2, Bax, Bcl-xl, Caspase-3) and changes of ERα, O-GlcNAc, OGT, OGA levels.Morris water maze results showed that DSS could improve the learning and memory abilities of female db/db mice. Nissl staining showed that DSS could relieve hippocampal neurons damage of db/db mice. In addition, the serological tests showed that DSS could improve the impaired glucose tolerance and insulin resistance, while reduce hyperlipemia in db/db mice. Besides, DSS treatment increased the activities of SOD, GSH-PX, and CAT, and reduced MDA, NO, iNOs, tNOS, PGE2, TXB2 and LTB4 levels. Western blot and immunofluorescence results of PSD95, BDNF, NGF, and SYN showed that DSS could improve the expressions of neurotrophic factors. Meanwhile, Tunel staning and Western blot (Bcl-2, Bax, Bcl-xl, Caspase-3) results indicated that DSS could reduce neuronal apoptosis. Finally, Western blot (ERα, O-GlcNAc, OGA, and OGT) and immunofluorescence (ERα and O-GlcNAc) results indicated that DSS could increase the levels of ERα and OGA, decrease the levels of O-GlcNAc and OGT.DSS alleviate DE might be related to improve the abnormal O-GlcNAc-modification of ERα.
    Keywords Oriental traditional medicine ; Western blotting ; apoptosis ; blood glucose ; blood lipids ; brain ; caspase-3 ; cognitive disorders ; estrogens ; females ; fluorescent antibody technique ; glucose ; glucose tolerance ; hyperlipidemia ; insulin resistance ; memory ; neurons ; oxidative stress ; therapeutics
    Language English
    Dates of publication 2021-1205
    Publishing place Elsevier B.V.
    Document type Article
    ZDB-ID 134511-4
    ISSN 1872-7573 ; 0378-8741
    ISSN (online) 1872-7573
    ISSN 0378-8741
    DOI 10.1016/j.jep.2021.114562
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  7. Article: Protective effects of Huang-Lian-Jie-Du Decoction on diabetic nephropathy through regulating AGEs/RAGE/Akt/Nrf2 pathway and metabolic profiling in db/db mice

    Tang, Dan / He, Wen-Jiao / Zhang, Zhi-Tong / Shi, Jing-Jing / Wang, Xue / Gu, Wen-Ting / Chen, Zhi-Quan / Xu, You-Hua / Chen, Yun-Bo / Wang, Shu-Mei

    Phytomedicine. 2022 Jan., v. 95

    2022  

    Abstract: Diabetic nephropathy (DN) is a severe diabetic complication that is the principal cause of end-stage kidney disease worldwide. Huang-Lian-Jie-Du Decoction (HLJDD) is widely used to treat diabetes clinically. However, the nephroprotective effects and ... ...

    Abstract Diabetic nephropathy (DN) is a severe diabetic complication that is the principal cause of end-stage kidney disease worldwide. Huang-Lian-Jie-Du Decoction (HLJDD) is widely used to treat diabetes clinically. However, the nephroprotective effects and potential mechanism of action of HLJDD against DN have not yet been fully elucidated.This study aimed to investigate the potential roles of HLJDD in DN and elucidate its mechanisms in db/db mice.An integrated strategy of network pharmacology, pharmacodynamics, molecular biology, and metabolomics was used to reveal the mechanisms of HLJDD in the treatment of DN. First, network pharmacology was utilized to predict the possible pathways for DN using the absorbed ingredients of HLJDD in rat plasma in silico. Then, combined with histopathological examination, biochemical evaluation immunohistochemistry/immunofluorescence assay, western blot analysis, and UPLC-Q-Orbitrap HRMS/MS-based metabolomics approach were applied to evaluate the efficacy of HLJDD against DN and its underlying mechanisms in vivo.In silico, network pharmacology indicated that the AGEs/RAGE pathway was the most prominent pathway for HLJDD against DN. In vivo, HLJDD exerted protective effects against DN by ameliorating glycolipid metabolic disorders and kidney injury. Furthermore, we verified that HLJDD protected against DN by regulating the AGEs/RAGE/Akt/Nrf2 pathway for the first time. In addition, 22 potential biomarkers were identified in urine, including phenylalanine metabolism, tryptophan metabolism, glucose metabolism, and sphingolipid metabolism.These findings suggest that HLJDD ameliorates DN by regulating the AGEs/RAGE/Akt/Nrf2 pathway and metabolic profiling.
    Keywords Western blotting ; biomarkers ; computer simulation ; diabetic nephropathy ; fluorescent antibody technique ; glucose ; glycolipids ; histopathology ; immunohistochemistry ; kidneys ; mechanism of action ; metabolism ; metabolomics ; molecular biology ; nephroprotective effect ; pharmacodynamics ; phenylalanine ; rats ; sphingolipids ; tryptophan ; urine
    Language English
    Dates of publication 2022-01
    Publishing place Elsevier GmbH
    Document type Article
    ZDB-ID 1205240-1
    ISSN 1618-095X ; 0944-7113
    ISSN (online) 1618-095X
    ISSN 0944-7113
    DOI 10.1016/j.phymed.2021.153777
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  8. Article ; Online: Quercetin protects against diabetic encephalopathy via SIRT1/NLRP3 pathway in db/db mice.

    Hu, Tian / Lu, Xin-Yi / Shi, Jing-Jing / Liu, Xiao-Qi / Chen, Qu-Bo / Wang, Qi / Chen, Yun-Bo / Zhang, Shi-Jie

    Journal of cellular and molecular medicine

    2020  Volume 24, Issue 6, Page(s) 3449–3459

    Abstract: Epidemiological studies have found that diabetes and cognitive dysfunction are closely related. Quercetin has been certified with the effect on improving diabetes mellitus (DM) and cognitive impairment. However, the effect and related mechanism of ... ...

    Abstract Epidemiological studies have found that diabetes and cognitive dysfunction are closely related. Quercetin has been certified with the effect on improving diabetes mellitus (DM) and cognitive impairment. However, the effect and related mechanism of quercetin on diabetic encephalopathy (DE) are still ambiguous. In this study, we used the db/db mice (diabetic model) to discover whether quercetin could improve DE through the Sirtuin1/NLRP3 (NOD-, LRR- and pyrin domain-containing 3) pathway. Behavioural results (Morris water maze and new object recognition tests) showed that quercetin (70 mg/kg) improved the learning and memory. Furthermore, quercetin alleviated insulin resistance and the level of fasting blood glucose. Besides, Western blot analysis also showed that quercetin increased the protein expressions of nerve- and synapse-related protein, including postsynapticdensity 93 (PSD93), postsynapticdensity 95 (PSD95), brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in the brain of db/db mice. Quercetin also increased the protein expression of SIRT1 and decreased the expression of NLRP3 inflammation-related proteins, including NLRP3, the adaptor protein ASC and cleaved Caspase-1, the pro-inflammatory cytokines IL-1β and IL-18. In conclusion, the present results indicate that the SIRT1/NLRP3 pathway may be a crucial mechanism for the neuroprotective effect of quercetin against DE.
    MeSH term(s) Animals ; Antioxidants/pharmacology ; Blood Glucose/drug effects ; Brain Diseases/pathology ; Brain Diseases/prevention & control ; Brain-Derived Neurotrophic Factor/metabolism ; Cognitive Dysfunction/pathology ; Cognitive Dysfunction/prevention & control ; Diabetes Mellitus/pathology ; Disks Large Homolog 4 Protein/metabolism ; Female ; Insulin Resistance/physiology ; Maze Learning/drug effects ; Mice ; Mice, Inbred C57BL ; Mice, Inbred NOD ; NLR Family, Pyrin Domain-Containing 3 Protein/metabolism ; Nerve Growth Factor/metabolism ; Quercetin/pharmacology ; Recognition, Psychology/drug effects ; Sirtuin 1/metabolism
    Chemical Substances Antioxidants ; Bdnf protein, mouse ; Blood Glucose ; Brain-Derived Neurotrophic Factor ; Disks Large Homolog 4 Protein ; Dlg4 protein, mouse ; NLR Family, Pyrin Domain-Containing 3 Protein ; Nlrp3 protein, mouse ; Nerve Growth Factor (9061-61-4) ; Quercetin (9IKM0I5T1E) ; Sirt1 protein, mouse (EC 3.5.1.-) ; Sirtuin 1 (EC 3.5.1.-)
    Language English
    Publishing date 2020-01-30
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2074559-X
    ISSN 1582-4934 ; 1582-4934 ; 1582-1838
    ISSN (online) 1582-4934
    ISSN 1582-4934 ; 1582-1838
    DOI 10.1111/jcmm.15026
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Protective effects of Huang-Lian-Jie-Du Decoction on diabetic nephropathy through regulating AGEs/RAGE/Akt/Nrf2 pathway and metabolic profiling in db/db mice.

    Tang, Dan / He, Wen-Jiao / Zhang, Zhi-Tong / Shi, Jing-Jing / Wang, Xue / Gu, Wen-Ting / Chen, Zhi-Quan / Xu, You-Hua / Chen, Yun-Bo / Wang, Shu-Mei

    Phytomedicine : international journal of phytotherapy and phytopharmacology

    2021  Volume 95, Page(s) 153777

    Abstract: Background: Diabetic nephropathy (DN) is a severe diabetic complication that is the principal cause of end-stage kidney disease worldwide. Huang-Lian-Jie-Du Decoction (HLJDD) is widely used to treat diabetes clinically. However, the nephroprotective ... ...

    Abstract Background: Diabetic nephropathy (DN) is a severe diabetic complication that is the principal cause of end-stage kidney disease worldwide. Huang-Lian-Jie-Du Decoction (HLJDD) is widely used to treat diabetes clinically. However, the nephroprotective effects and potential mechanism of action of HLJDD against DN have not yet been fully elucidated.
    Purpose: This study aimed to investigate the potential roles of HLJDD in DN and elucidate its mechanisms in db/db mice.
    Methods: An integrated strategy of network pharmacology, pharmacodynamics, molecular biology, and metabolomics was used to reveal the mechanisms of HLJDD in the treatment of DN. First, network pharmacology was utilized to predict the possible pathways for DN using the absorbed ingredients of HLJDD in rat plasma in silico. Then, combined with histopathological examination, biochemical evaluation immunohistochemistry/immunofluorescence assay, western blot analysis, and UPLC-Q-Orbitrap HRMS/MS-based metabolomics approach were applied to evaluate the efficacy of HLJDD against DN and its underlying mechanisms in vivo.
    Results: In silico, network pharmacology indicated that the AGEs/RAGE pathway was the most prominent pathway for HLJDD against DN. In vivo, HLJDD exerted protective effects against DN by ameliorating glycolipid metabolic disorders and kidney injury. Furthermore, we verified that HLJDD protected against DN by regulating the AGEs/RAGE/Akt/Nrf2 pathway for the first time. In addition, 22 potential biomarkers were identified in urine, including phenylalanine metabolism, tryptophan metabolism, glucose metabolism, and sphingolipid metabolism.
    Conclusion: These findings suggest that HLJDD ameliorates DN by regulating the AGEs/RAGE/Akt/Nrf2 pathway and metabolic profiling.
    MeSH term(s) Animals ; Coptis chinensis ; Diabetes Mellitus ; Diabetic Nephropathies/drug therapy ; Drugs, Chinese Herbal/pharmacology ; Metabolomics ; Mice ; NF-E2-Related Factor 2 ; Network Pharmacology ; Proto-Oncogene Proteins c-akt ; Rats
    Chemical Substances Drugs, Chinese Herbal ; NF-E2-Related Factor 2 ; Proto-Oncogene Proteins c-akt (EC 2.7.11.1)
    Language English
    Publishing date 2021-09-27
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 1205240-1
    ISSN 1618-095X ; 0944-7113
    ISSN (online) 1618-095X
    ISSN 0944-7113
    DOI 10.1016/j.phymed.2021.153777
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Carnosine Improves Cognitive Impairment Through Promoting SIRT6 Expression and Inhibiting Endoplasmic Reticulum Stress in a Diabetic Encephalopathy Model.

    Peng, Dong / Xia, Qing / Guan, Li / Li, Hong-Ying / Qiao, Li-Jun / Chen, Yun-Bo / Cai, Ye-Feng / Wang, Qi / Zhang, Shi-Jie

    Rejuvenation research

    2021  Volume 25, Issue 2, Page(s) 79–88

    Abstract: Diabetic encephalopathy (DE) is one of complications of diabetes mellitus. Carnosine is a dipeptide composed of β-alanine and l-histidine. Study has shown that carnosine could ameliorate cognitive impairment in animal model with diabetes mellitus. ... ...

    Abstract Diabetic encephalopathy (DE) is one of complications of diabetes mellitus. Carnosine is a dipeptide composed of β-alanine and l-histidine. Study has shown that carnosine could ameliorate cognitive impairment in animal model with diabetes mellitus. However, the mechanism remains unclear. An animal model of type 2 diabetes (db/db mice) was used in this study. The animals were treated with 0.9% saline or carnosine (100 mg/kg) for 8 weeks. Morris water maze was tested after drug administration. Oxidative stress-related factors malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-PX), and pro-inflammatory factors inducible nitric oxide synthase (iNOS) were measured. Synapse-related protein postsynaptic density 95 (PSD95) and brain-derived neurotrophic factor (BDNF) were detected by western blot. Besides, the expressions of sirtuin 6 (SIRT6), binding immunoglobulin protein (BIP), protein kinase R-like endoplasmic reticulum kinase (PERK), phospho-protein kinase R-like endoplasmic reticulum kinase (P-PERK), inositol-requiring enzyme-1α (IRE1α), phospho-inositol-requiring enzyme-1α (P-IRE1α), activating transcription factor 6 (ATF6), and C/EBP-homologous protein (CHOP) in the hippocampus of the brain were detected. The results showed that treatment with carnosine ameliorated cognitive impairment in db/db mice. Carnosine reduced neuronal oxidative stress damage and iNOS expression in db/db mice. Meanwhile, carnosine relieved neurodegeneration in the hippocampus of db/db mice. Furthermore, carnosine promoted the expression of SIRT6 and reduced the expressions of endoplasmic reticulum (ER)-related factors (BIP, P-PERK, P-IRE1α, ATF6, and CHOP). In conclusion, these data suggested that the protective effect of carnosine against DE might be related to SIRT6/ER stress pathway.
    MeSH term(s) Animals ; Apoptosis ; Brain Diseases ; Carnosine/pharmacology ; Carnosine/therapeutic use ; Cognitive Dysfunction/drug therapy ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/drug therapy ; Endoplasmic Reticulum Stress ; Endoribonucleases/genetics ; Mice ; Protein Serine-Threonine Kinases ; Sirtuins/genetics
    Chemical Substances Carnosine (8HO6PVN24W) ; Sirt6 protein, mouse (EC 2.4.2.31) ; Protein Serine-Threonine Kinases (EC 2.7.11.1) ; Endoribonucleases (EC 3.1.-) ; Sirtuins (EC 3.5.1.-)
    Language English
    Publishing date 2021-07-02
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2150779-X
    ISSN 1557-8577 ; 1549-1684
    ISSN (online) 1557-8577
    ISSN 1549-1684
    DOI 10.1089/rej.2022.0002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top